Whole exome sequencing, 90% at 20X with 1-2% failure rate (buccal/blood) for NCI (haiman)

Ended Awarded Last action

Contract number
75N92022F00010
Awardee
Awarding agency
Obligated
$3,325,000

Award facts

Contract value 100% obligated
$3,325,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Cancer Institute National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21218, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $3,325,000

About this award

The U.S. National Cancer Institute (NCI) awarded a $3,325,000.00 firm-fixed-price delivery order contract to The Johns Hopkins University for whole exome sequencing services. The contract, which does not have a set-aside designation, will run through December 31, 2025. The order requires 90% sequencing at 20X coverage with a 1-2% failure rate, using buccal or blood samples. As a leading research university, Johns Hopkins has extensive experience supporting federal biomedical research initiatives through prime and subcontracts. This task order is part of a larger indefinite delivery contract with the Centers for Disease Control and Prevention (CDC) that provides immunization safety research and consultation services to advance the CDC's national immunization programs.

Quick answers

Who was awarded contract 75N92022F00010?

75N92022F00010 was awarded to The Johns Hopkins University by National Heart Lung and Blood Institute (National Institutes of Health) on September 20, 2022.

How much is contract 75N92022F00010 worth?

The government has obligated $3,325,000 on 75N92022F00010.

Which agency awarded contract 75N92022F00010?

National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92022F00010, with funding from National Cancer Institute (National Institutes of Health).

Is contract 75N92022F00010 an order under another contract?

Yes. 75N92022F00010 is a delivery order under HHSN268201700006I, an indefinite delivery contract.

Was contract 75N92022F00010 competed?

The extent of competition for 75N92022F00010 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award